14 April 2009: The Board of Directors of NorDiag ASA calls for the Annual General Meeting of NorDiag to be held on Wednesday 29 April 2009 at 10:00 hours at the company's office in Frysjaveien 40, entrance 12, 4th floor, 0884 Oslo, Norway.

The agenda includes, in addition to approval of the annual accounts for the financial year 2008, and other customary matters for the ordinary general meeting, proposed changes in the company's Articles of Association in respect of a share consolidation and a related share issue. As the market value of the company's shares shall not be lower than NOK 1 pursuant to the company's continuing obligations as a company listed at the Oslo Børs, and the share price has been lower than this since 7 November 2008, the Board proposes that a share consolidation in the ratio 10:1 is carried out by increasing the nominal value of the shares by NOK 0.90 from NOK 0.10 to NOK 1.00, so that 10 shares are consolidated into 1. This requires a share issue of 4 new shares prior to the consolidation so that a round number of shares is achieved.

The annual report was released March 19 2009, and is published on the company's webpage www.nordiag.com.

Complete notice is attached.

Contact: CFO Tone Kvåle, telephone + 47 915 19576.

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions, instruments and tests, for use in diagnostic of infectious diseases and cancer. The Company`s core competence is isolation of bacterial and human DNA from difficult clinical samples, and the Company has established a solid market share in the Scandinavian market for sexually transmitted infections. The company has similar applications for Tuberculosis, MRSA and DNA from stool. Applications for respiratory pathogens and viruses are under development. NorDiag was founded in 2003 and has its headquarters in Oslo - Norway. The Company has offices and laboratories in Stockholm - Sweden and West Chester (PA) - USA. The group has 36 employees. NorDiag is listed on Oslo Stock Exchange with the ticker NORD.

For further information - www.nordiag.com.

Read the attachment here.

Read the notice in Norwegain here.